NIKA OTC
Nika Pharmaceuticals Inc.
1W: +0.0%
1M: +0.0%
3M: -7.7%
YTD: +7.9%
1Y: +40.6%
$0.41
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$76K
+20.2% ▲
Net Income
-$76K
+20.2% ▲
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
-$76K
+20.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | — | — | — | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $3M | $0 | $0 | $0 |
| SG&A Expenses | $15K | $184K | $65K | $96K | $76K |
| Operating Expenses | $15K | $3M | $65K | $96K | $76K |
| Operating Income | -$15K | -$3M | -$65K | -$96K | -$76K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$15K | -$3M | -$65K | -$96K | -$76K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$15K | -$3M | -$65K | -$96K | -$76K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$15K | -$3M | -$65K | -$96K | -$76K |
| Shares Outstanding | 876M | 876M | 876M | 1.02B | 1.05B |